Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

499 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Comparison between epidermal growth factor receptor (EGFR) gene expression in primary non-small cell lung cancer (NSCLC) and in fine-needle aspirates from distant metastatic sites.
Bozzetti C, Tiseo M, Lagrasta C, Nizzoli R, Guazzi A, Leonardi F, Gasparro D, Spiritelli E, Rusca M, Carbognani P, Majori M, Franciosi V, Rindi G, Ardizzoni A. Bozzetti C, et al. Among authors: ardizzoni a. J Thorac Oncol. 2008 Jan;3(1):18-22. doi: 10.1097/JTO.0b013e31815e8ba2. J Thorac Oncol. 2008. PMID: 18166836 Free article.
Etoposide versus etoposide plus high-dose cisplatin in the management of advanced non-small cell lung cancer. Results of a prospective randomized FONICAP trial. Italian Lung Cancer Task Force.
Rosso R, Salvati F, Ardizzoni A, Gallo Curcio C, Rubagotti A, Belli M, Castagneto B, Fusco V, Sassi M, Ferrara G, et al. Rosso R, et al. Among authors: ardizzoni a. Cancer. 1990 Jul 1;66(1):130-4. doi: 10.1002/1097-0142(19900701)66:1<130::aid-cncr2820660123>3.0.co;2-p. Cancer. 1990. PMID: 2162239 Clinical Trial.
Mitomycin-ifosfamide-cisplatinum (MIP) vs MIP-interferon vs cisplatinum-carboplatin in metastatic non-small-cell lung cancer: a FONICAP randomised phase II study. Italian Lung Cancer Task Force.
Ardizzoni A, Addamo GF, Baldini E, Borghini U, Portalone L, De Marinis F, Lionetto R, Conte PF, Bruzzi P, Pennucci MC, et al. Ardizzoni A, et al. Br J Cancer. 1995 Jan;71(1):115-9. doi: 10.1038/bjc.1995.23. Br J Cancer. 1995. PMID: 7529522 Free PMC article. Clinical Trial.
Combination of chemotherapy and recombinant alpha-interferon in advanced non-small cell lung cancer. Multicentric Randomized FONICAP Trial Report. The Italian Lung Cancer Task Force.
Ardizzoni A, Salvati F, Rosso R, Bruzzi P, Rubagotti A, Pennucci MC, Mariani GL, De Marinis F, Pallotta G, Antilli A, et al. Ardizzoni A, et al. Cancer. 1993 Nov 15;72(10):2929-35. doi: 10.1002/1097-0142(19931115)72:10<2929::aid-cncr2820721012>3.0.co;2-x. Cancer. 1993. PMID: 8221559 Clinical Trial.
Cisplatin-vindesine-mitomycin (MVP) vs cisplatin-ifosfamide-vinorelbine (PIN) vs carboplatin-vinorelbine (CaN) in patients with advanced non-small-cell lung cancer (NSCLC): a FONICAP randomized phase II study. Italian Lung Cancer Task Force (FONICAP).
Baldini E, Tibaldi C, Ardizzoni A, Salvati F, Antilli A, Portalone L, Barbera S, Romano F, De Marinis F, Migliorino MR, Noseda MA, Borghini U, Crippa M, Ferrara G, Raimondi M, Fioretti M, Bandera M, Pennucci MC, Galeasso G, Cacciani GC, Lepidini G, Sunseri G, Lanfranco C, Rinaldi M, Rosso R, et al. Baldini E, et al. Among authors: ardizzoni a. Br J Cancer. 1998 Jun;77(12):2367-70. doi: 10.1038/bjc.1998.393. Br J Cancer. 1998. PMID: 9649160 Free PMC article. Clinical Trial.
499 results